MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
about
miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.Epigenetic Bases of Aberrant Glycosylation in Cancer.Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway.Downregulation of cyclin-dependent kinase 8 by microRNA-148a suppresses proliferation and invasiveness of papillary thyroid carcinomas.Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysis
P2860
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
@en
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
@nl
type
label
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
@en
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
@nl
prefLabel
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
@en
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.
@en
P2093
Ai-Gang Yang
Hai-Su Dai
Hao-Wei Chen
Jia-Xin Tan
Lian-Hua Bai
Xue-Jun Xu
Yu-Jun Zhang
P2860
P304
57099-57116
P356
10.18632/ONCOTARGET.10981
P407
P577
2016-08-01T00:00:00Z